BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34721578)

  • 1. Comparative Recurrence Analysis of Pancreatic Adenocarcinoma after Resection.
    He C; Cai Z; Zhang Y; Lin X
    J Oncol; 2021; 2021():3809095. PubMed ID: 34721578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Quantitative Clinicopathological Signature for Predicting Recurrence Risk of Pancreatic Ductal Adenocarcinoma After Radical Resection.
    He C; Huang X; Zhang Y; Cai Z; Lin X; Li S
    Front Oncol; 2019; 9():1197. PubMed ID: 31781499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Nomogram to Predict Survival in Patients With Recurrence of Pancreatic Ductal Adenocarcinoma After Radical Resection.
    He C; Sun S; Zhang Y; Lin X; Li S
    Front Oncol; 2020; 10():1564. PubMed ID: 33014805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alkaline Phosphatase-To-Albumin Ratio as a Prognostic Indicator in Pancreatic Ductal Adenocarcinoma after Curative Resection.
    Pu N; Gao S; Xu Y; Zhao G; Lv Y; Nuerxiati A; Li JA; Wang D; Xu X; Kuang T; Wang X; Lou W; Liu L; Wu W
    J Cancer; 2017; 8(16):3362-3370. PubMed ID: 29158809
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic Nomogram for Patients With Pancreatic Ductal Adenocarcinoma of Pancreatic Head After Pancreaticoduodenectomy.
    Zhuang H; Zhou Z; Ma Z; Huang S; Gong Y; Li Z; Liu C; Wang S; Chen B; Zhang C; Hou B
    Clin Med Insights Oncol; 2021; 15():11795549211024149. PubMed ID: 34211308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma.
    Malleo G; Maggino L; Ferrone CR; Marchegiani G; Luchini C; Mino-Kenudson M; Paiella S; Qadan M; Scarpa A; Lillemoe KD; Bassi C; Fernàndez-Del Castillo C; Salvia R
    Ann Surg Oncol; 2020 Oct; 27(10):3898-3912. PubMed ID: 32307617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of intratumoral fluid-containing area by magnetic resonance imaging to predict prognosis in patients with pancreatic ductal adenocarcinoma after curative resection.
    Kim H; Kim DH; Song IH; Youn SY; Kim B; Oh SN; Choi JI; Rha SE
    Eur Radiol; 2022 Apr; 32(4):2518-2528. PubMed ID: 34671833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Tumor Location on Resection and Survival for Pancreatic Ductal Adenocarcinoma.
    Winer LK; Dhar VK; Wima K; Morris MC; Lee TC; Shah SA; Ahmad SA; Patel SH
    J Surg Res; 2019 Jul; 239():60-66. PubMed ID: 30802706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma.
    Van den Broeck A; Sergeant G; Ectors N; Van Steenbergen W; Aerts R; Topal B
    Eur J Surg Oncol; 2009 Jun; 35(6):600-4. PubMed ID: 19131205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between primary origin (head, body and tail) of metastasised pancreatic ductal adenocarcinoma and oncologic outcome: A population-based analysis.
    Mackay TM; van Erning FN; van der Geest LGM; de Groot JWB; Haj Mohammad N; Lemmens VE; van Laarhoven HW; Besselink MG; Wilmink JW;
    Eur J Cancer; 2019 Jan; 106():99-105. PubMed ID: 30476732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis.
    van Erning FN; Mackay TM; van der Geest LGM; Groot Koerkamp B; van Laarhoven HWM; Bonsing BA; Wilmink JW; van Santvoort HC; de Vos-Geelen J; van Eijck CHJ; Busch OR; Lemmens VE; Besselink MG;
    Acta Oncol; 2018 Dec; 57(12):1655-1662. PubMed ID: 30264642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma.
    Rittmann MC; Hussung S; Braun LM; Klar RFU; Biesel EA; Fichtner-Feigl S; Fritsch R; Wittel UA; Ruess DA
    Sci Rep; 2021 Apr; 11(1):7499. PubMed ID: 33820913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic ductal adenocarcinoma: a radiomics nomogram outperforms clinical model and TNM staging for survival estimation after curative resection.
    Xie T; Wang X; Li M; Tong T; Yu X; Zhou Z
    Eur Radiol; 2020 May; 30(5):2513-2524. PubMed ID: 32006171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent effect of postoperative neutrophil-to-lymphocyte ratio on the survival of pancreatic ductal adenocarcinoma with open distal pancreatosplenectomy and its nomogram-based prediction.
    Pu N; Yin H; Zhao G; Nuerxiati A; Wang D; Xu X; Kuang T; Jin D; Lou W; Wu W
    J Cancer; 2019; 10(24):5935-5943. PubMed ID: 31762803
    [No Abstract]   [Full Text] [Related]  

  • 15. A Simple Model Established by Blood Markers Predicting Overall Survival After Radical Resection of Pancreatic Ductal Adenocarcinoma.
    Zhang LX; Chen L; Xu AM
    Front Oncol; 2020; 10():583. PubMed ID: 32426277
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic value of γ-glutamyltransferase-to-albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgery.
    Li S; Xu H; Wu C; Wang W; Jin W; Gao H; Li H; Zhang S; Xu J; Zhang W; Xu S; Li T; Ni Q; Yu X; Liu L
    Cancer Med; 2019 Feb; 8(2):572-584. PubMed ID: 30632317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.
    Kim NH; Kim HJ
    Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):450-455. PubMed ID: 30237091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Total Pancreatectomy on Survival of Patients With Pancreatic Ductal Adenocarcinoma: A Population-Based Study.
    Shao W; Lu Z; Xu J; Shi X; Tan T; Xing C; Song J
    Front Surg; 2021; 8():804785. PubMed ID: 34957210
    [No Abstract]   [Full Text] [Related]  

  • 19. The prognostic relevance of primary tumor location in patients undergoing resection for pancreatic ductal adenocarcinoma.
    Ling Q; Xu X; Ye P; Xie H; Gao F; Hu Q; Liu Z; Wei X; Röder C; Trauzold A; Kalthoff H; Zheng S
    Oncotarget; 2017 Feb; 8(9):15159-15167. PubMed ID: 28122349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study.
    Gbolahan OB; Tong Y; Sehdev A; O'Neil B; Shahda S
    BMC Cancer; 2019 May; 19(1):468. PubMed ID: 31101022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.